Penetratin and Derivatives Acting as Antibacterial Agents by Garro, Adriana D. et al.
Penetratin and Derivatives Acting as Antibacterial Agents 
 
Adriana D. Garro, Mónica S. Olivella, José A. Bombasaro, Beatriz Lima, Alejandro Tapia, 
Gabriela Feresin, Andras Percze, Csaba Somlai, Botond Penke, Javier López Cascales, Ana 
M. Rodríguez, Ricardo D. Enriz 
 
 
Small cationic peptides [1, 2] are abundant in nature and have been described as ‘nature′s 
antibiotics’ or ‘cationic antimicrobial peptides’. They are found in every complex species [3] 
and are generally defined as having 12 to about 50 amino acids with 2–9 positively charged K 
or R residue and up to 50% hydrophobic amino acids. These peptides are folded in three 
dimensions, so that they have both a hydrophobic face comprising non-polar amino acid side 
chains, and a hydrophilic face of polar and positively charged residues: these molecules are 
amphipathic. The nature of the primary structure of cationic peptides appears to be of great 
significance for the activity, as a high content of cationic amino acids is a prerequisite for 
their initial association with negatively charged membrane components [4, 5]. The ratio 
between the cationic K and R residues influences membrane selectivity as the guanidino 
functionalities of R promote a more efficient interaction with eukaryotic membranes as 
compared with K. However, a high K content has been correlated with selectivity towards 
bacterial cells over eukaryotic cells [6]. Another important factor reported for some 
antimicrobial peptides is related to their propensity to fold into a well-defined secondary 
structure (i.e. α-helix); thus, the antimicrobial activity of α-helical antimicrobial peptides 
depends on their propensity to form an α-helix [7, 8]. 
 
Joliot et al. [9] reported that the 60 amino acid homeodomain of the Antennapedia protein of 
Drosophila was able to translocate over cell membranes. In order to understand the driving 
force for the internalization, the homeodomain was modified by site-directed mutagenesis 
leading to the discovery that its third helix was necessary and also sufficient for membrane 
translocation, which resulted in the development of a 16 amino acid-long cell-penetrating 
peptide (CPP) called penetratin [10]. Thus, penetratin [1], a synthetic 16-amino acid peptide 
from the third helix of Antennapedia homeodomain [10, 11], is a cationic amphipathic peptide 
and might penetrate cell membrane via a postulated ‘inverted micelle’ pathway. Penetratin has 
been proposed as a universal intracellular delivery vehicle [12]. Thus, there are in the 
literature many articles reporting the cell-penetrating properties associated with penetratin 
[13-15]. In addition, there is much information about the structural aspects of this interesting 
peptide as well [16, 17]. Regarding the antimicrobial activities, the antifungal activity of 
penetratin against Candida albicans (C. albicans) and Cryptococcus neoformans (C. 
neoformans) was first reported by our group [18]. Moreover, the antibacterial effects of this 
CPP have been demonstrated [19-22]. Activity against both Gram-positive [19-21] and Gram-
negative [21] bacteria has been reported for native penetratin. More recently, Bahnsen et al. 
[22] have reported the antimicrobial effects of penetratin and several derivatives of this CPP. 
It is interesting to remark that penetratin did not show cytotoxic effects against mammalian 
cells [20, 22]. Zhu and Shin [20] reported that two-stranded penetratin markedly increased 
cytolytic activity against human erythrocytes and NIH-3T3 mouse fibroblast cells without a 
significant effect on antimicrobial activity. 
 
Peptides capable of both internalization into mammalian cells and killing of bacterial 
pathogens might well constitute potential candidates to search new structures as antibacterial 
agents. Thus, in this study, we tested first penetratin and other previously reported derivatives 
against several pathogenic bacteria. To better characterize the structure–antibacterial activity 
relationship of penetratin and derivatives, we also synthesized and tested new peptides 
structurally related to penetratin. The present search explored influences of amino acid 
substitutions and deletions on its antibacterial activity. In addition, to determine the 
tridimensional structure of peptides reported here, an exhaustive conformational analysis of 
penetratin and its derivatives was carried out using different approaches. Molecular dynamics 
(MD) simulations were carried out using two different media, water and a mixture of 
trifluoroethanol (TFE) and water trying to simulate the peptides inserted in the membrane. 
These theoretical simulations were corroborated using experimental circular dichroism (CD) 
measurements for the most representative compounds in this series. Thus, the ability of each 
approach to obtain the different conformations was tested and compared. An electronic study 
for these peptides was carried out using molecular electrostatic potentials (MEPs) obtained 
from RHF/6-31G(d) calculations. This conformational and electronic study was carried out in 
order to identify a topographical and/or substructural template, which may be the starting 
structure for the design of new peptides with the ability to inhibit bacterial growth. Finally, we 
extended our study synthesizing and testing new small-size peptides structurally related to 
penetratin. The principal goal was to obtain new small-size peptides, which were short in size 
but of full antibacterial potential. 
 
 
Results and Discussion 
Antibacterial activity 
We first tested penetratin (peptide 1 in Table 1), which showed just a moderate antibacterial 
effect. In particular, this peptide displayed antibacterial activity against Escherichia coli 
ATCC 25922, LM1-Escherichia coli, LM2-Escherichia coli and Salmonella sp (LM). In 
contrast, peptide 1 was devoid of any significant antibacterial activity against Staphylococcus 
aureus methicillin-sensitive ATCC 29213, Staphylococcus aureus methicillin-resistant ATCC 
43300, Pseudomonas aeruginosa ATCC 27853, PI-Yersinia enterocolitica and MI-Salmonella 
enteritidis. Earlier investigations on the antibacterial activity of penetratin against E. coli 
reported MIC values of: 25 μm (K12) [19], 32 μm (ATCC 25922) [22] and 2 μm (KCTC 
1682) in a low nutrition 1% (w/v) peptone solution [21]. It is clear that our present results are 
in complete agreement with those reported in references [19] and [22]. Also, we extended our 
study measuring the MICs of penetratin towards LM1-E. coli and LM2-E. coli, which 
displayed a similar sensibility (40 and 25 μm, respectively; Table 1). 
 
Table 1. Antibacterial activity of penetratin and derivatives 
Compounds                                                                                  MICa (μm) 
                                                  S.a (ms) S.a (mr) E.c.LM1-E.c.LM2- E.c.Ps.a.PI-Y.e.MI-S.e. S sp (LM) 
RQIKIWFQNRRMKWKK-NH2 (1) >50 >50 25 40 25 >50 >50 >50 50 
KKWKMRRNQFWIKIQR-NH2 (2) >50 >50 >50 25 25 >50 >50 25 25 
RWWKWWWWWRRWKWKK-NH2 (3) >50 >50 >50 >50 50 >50 >50 25 50 
RQIRIWFQNRRMRWRR-NH2 (4) >50 >50 25 25 25 >50 >50 25 50 
KQIKIWFQNKKMKWKK-NH2 (5) >50 >50 >50 12.5 25 >50 >50 25 50 
RQIKIWFQNRRM[O]KWKK-NH2 (6) >50 >50 12.5 12.5 25 >50 25 25 25 
RQIKIFFQNRRM[O]KFKK-NH2 (7) >50 >50 50 12.5 12.5 >50 >50 12.5 25 
KQIKIWFQNKKM[O]KWKK-NH2 (8) >50 >50 >50 25 50 >50 >50 25 50 
NRRMKWKK-NH2 (9) >50 >50 >50 >50 >50 >50 >50 >50 >50 
RQIRRWWQR-NH2 (10) 50 25 25 12.5 12.5 >50 25 25 25 
RQIRRWWQW-NH2 (11) >50 >50 >50 40 >50 >50 >50 >50 30 
RQIWRWWQW-NH2 (12) >50 >50 >50 50 >50 >50 >50 >50 50 
RKFRRKFKK-NH2 (13) >50 >50 >50 >50 >50 >50 >50 >50 >50 
RQIRWQR-NH2 (14) >50 >50 >50 >50 >50 >50 >50 >50 >50 
RQIRW-NH2 (15) >50 >50 >50 >50 >50 >50 >50 >50 >50 
Cefb 0.5 0.5 0.5 5 0.5 7.5 0.5 12.5 0.5 
 
To study the structure–antibacterial activity relationship on this family of CPP, different 
penetratin derivatives and the effects of structural changes in their sequences were considered. 
Thus, we synthesized and tested peptides 2–5 (Table 1). It should be noted that compound 2 is 
the retro–inverso of penetratin, namely the position of the carbonyl and amino groups in each 
of the amide bonds of the polypeptide backbone was reversed, conferring a strong resistance 
to the peptide towards various proteases [41, 42]. The retro–inverso modification in peptides 
is a peptidomimetic approach able to transform short-lived biologically active peptides into 
much more stable molecules that retain their activity and are suitable for therapeutic use. 
Building the peptide in the reverse sense opposes the effect of the chirality inversion, thus 
leading to a high degree of topochemical equivalence, with the amino acid side chains 
properly arranged in space. In peptide 3, the residues Q, I, F, N and M of peptide 1 were 
replaced by W, thereby increasing the number of hydrophobic residues. It has been 
demonstrated that the presence of a significant number of hydrophobic residues along the 
sequence of these cationic antimicrobial peptides is also of importance for their biological 
effect [17]. Peptides 4 and 5 are analogues of 1 rich in R and K residues, respectively. In 
peptide 4, all K residues of peptide 1 were replaced by R residues, while in peptide 5, all R 
residues were substituted for K residues. All these derivatives (compounds 2–5) showed an 
antibacterial activity slightly stronger than penetratin (Table 1). Note that compounds 
possessing in their sequence a larger number of cationic residues (peptides 4 and 5) displayed 
better antibacterial effect in comparison with that obtained for peptides 3 (rich in W) and 2 
(the retro–inverso of penetratin). Although derivatives 2, 4 and 5 displayed an antimicrobial 
activity more potent than penetratin, they were just slightly better than this peptide. Our 
results are in good agreement with the antimicrobial effect against E. coli (ATCC 25922) 
reported for compounds 4 and 5 in reference [22]. In addition, we obtained a significant 
antibacterial effect against LM1-E. coli and LM2-E. coli for both peptides. 
 
On the basis of these results in the next step of our study, we attempted to obtain new peptides 
possessing more potent antibacterial activity. Previously, we reported that a particular 
combination of cationic and hydrophobic residues adopting a definite spatial ordering appears 
to be the key parameter for the transition from hydrophilic to hydrophobic phase, which could 
be a necessary step for these CPP to produce the antifungal activity [18, 25, 26]. Now, we 
considered the possibility that a polarity increase at the M residue may contribute to obtain a 
better electronic distribution in this moiety of the peptides which might facilitate the 
penetration of these compounds as well as their antimicrobial effects. In order to evaluate 
such situation, we performed a comparative conformational and electronic study of peptides 1 
and 6. In peptide 6, M residue of peptide 1 was replaced by M-[O] (methionine sulphoxide or 
methionine sulphone). An evident change on the electronic distribution in the vicinity of M 
and M-[O)] residues and their respective influence zone was obtained from the MEPs 
calculated for compounds 1 and 6 (see the results obtained from MEPs calculations). Due to 
these theoretical results, peptide 6 was synthesized and tested. Interestingly, compound 6 
displayed a marked increase in the antibacterial effect in comparison to that obtained for 
penetratin. Table 1 shows a comparison of the MIC values obtained against E. coli ATCC 
25922, LM1-E. coli, LM2-E. coli, PI-Y. enterocolitica, MI-S. enteritidis and Salmonella sp 
(LM) for both peptides (1 and 6). 
 
On the basis of the above results, peptides 7 and 8 possessing M-[O] residue in their structures 
were synthesized. Although both compounds displayed antibacterial effects, compound 7 was 
the most active peptide of this series. Peptide 7 showed antibacterial activity against LM1-E. 
coli, LM2-E. coli, MI-S. enteritidis and Salmonella sp (LM), being the first three the most 
sensible species. It is interesting to note that this compound yielded a significant inhibition 
percentage even at low concentrations (100% of inhibitory effect was observed at 12.5 μm). 
The inhibitory effect observed against Salmonella sp (LM) was lower than that obtained for 
MI-S. enteritidis, although it was still significant. 
 In summary, from the analysis of the antibacterial effects of peptides 1–8, it is possible to 
infer that methionine sulphoxide derivatives exhibited the strongest activities in this series. In 
order to further understand the above experimental results, an exhaustive conformational and 
electronic study of the peptides reported here was performed using different approaches. 
These results are presented in the next section. 
 
Conformational study of penetratin and derivatives 
In order to better interpret the experimental results, a comparative conformational and 
structural study of this peptide series was carried out. To this end, two peptides without M-[O] 
residue in their structure (peptides 1 and 2) and three peptides possessing M-[O] residue in 
their sequence (peptides 6, 7 and 8) were selected. Linear peptides are highly flexible and 
therefore to determine the biologically relevant conformations is not an easy task. In a 
previous study [18], we performed an extensive conformational study of penetratin (1) using 
molecular mechanics, simulated annealing and MD simulations. From those theoretical 
results, we concluded that the three methods predicted a helix-like structure as the preferred 
form for peptide 1 in water solution. Others studies have suggested that this peptide in 
solution is either partially α-helical [43, 44] or has a partial β-hairpin structure [45]. On the 
other hand, experimental CD studies have demonstrated that, in aqueous solution, penetratin 
[46, 47] and analogues [23, 24] existed predominantly as a random coil, but in a membrane-
mimetic environment, these peptides displayed a clear tendency to form α-helical 
conformations. The structure determination from MD calculations may be used to monitor 
changes induced by the variation in the polarity of the molecular environment. Thus, peptides 
2, 6, 7 and 8 were simulated using an extracellular matrix-mimetic environment and a 
membrane-mimetic environment. The aqueous solution simulated the extracellular matrix, 
while solutions containing TFE mimicked a membrane-like molecular environment. 
Molecular dynamics simulations were completed in water and in a mixture of TFE and water 
(3:7). 
 
Peptide structure in highly aqueous medium 
Figure 1 shows the change in the secondary structure during 100 ns of MD simulation in 
water for peptides 6 (a) and 7 (b). Simulations obtained for peptides 2 and 8 are shown in 
Figure S1 (in Supporting information). For peptides 2, 6 and 8, the initial conformation 
returned and remained stable in these simulations, suggesting that the starting helical structure 
was destroyed to form a mixture of α-helix, β-turn and bend in the structure at residues 2–15. 
Such a conformational behaviour was observed until the end of the simulation. The initial and 
final amino acids appear to have a random coil structure because of the flexibility of these 
residues. These results are closely related to those previously reported for penetratin [18]. In 
contrast, peptide 7 displayed a different conformational behaviour. In this case, a mixture of 
coil, bend and turn conformations was formed after 70 ns of simulation. This mixture was 
observed until the end of the simulation. 
 
Peptide structure in a low dielectric environment 
Figure 1 shows the change in the secondary structure during 100 ns of MD simulation in 
TFE/water system for peptides 6 (c) and 7 (d). Simulations obtained for peptides 2 and 8 are 
shown in Figure S2 (in Supporting information). Peptide 1 was also included in this figure 
because it has been not previously reported in this environment. All the simulations 
performed using the TFE/water environment yielded very similar results. Residues 2–15 
adopt a helix-like conformation, being the α-helix the predominant form. Once again the 
initial and final residues appear to have a random coil structure. Figure 2 shows a snapshot of 
the peptide 1/TFE/water system at 80 ns of the MD simulation displaying the spatial 
orientation of this peptide in the membrane-like phase. Similar results were obtained for the 
rest of peptides reported here, being the results for peptide 1 representative of this series. 
 
 
Structure of peptides based on CD spectra 
To corroborate the above theoretical results, in the next step, CD spectroscopic measurements 
were performed both in water and in a mixture of TFE and water (3:7) for peptides 7 and 8, 
which possess M-[O] residue in their structures. They were measured at room temperature 
using the following conditions (pH adjusted by HCl/NaOH solutions); concentration: 0.023 
mm; pH = 6.7. The exhaustive spectral analysis revealed that in water, peptides 7 and 8 
existed predominantly as a random coil structure (Figure 3, black lines). The ‘U’-type CD 
spectra reflected the presence of a very large number of different local conformations in a 
time average manner. Hence, in water, from the shape of these U-type CD curves, little 
characteristic secondary structure content could be extracted for any of these peptides (black 
lines). When the same peptides were recorded in the solvent mixture of 30% TFE and 70% 
H2O, significant changes in the shape of both curves were observed. The CD curves of 
polypeptides 7 and 8 (see red lines in Figure 3A, B, respectively) had spectral features similar 
to those of a C-type CD curve. Thus, the ‘red curves’ most probably reflected a 
conformational ensemble composed of α- or 310-helix combined with type I/III β-turns plus 
some percentage of still unstructured (or highly mobile) backbone foldamers. These results 
indicate that in the presence of a considerable amount of TFE, peptides 7 and 8 adopt an 
increased amount of helical and/or type I/III β-turn secondary structure. These results are in 
agreement with those previously obtained for penetratin [44, 45] (peptide 1) and retro–inverso 
of penetratin [23] (peptide 2). It is interesting to remark that these experimental measurements 
are also in complete agreement with our theoretical results giving an additional support to the 
MD simulations reported here. 
 
 
To better characterize the spatial orientation of these peptides, Edmunson wheel 
representations of peptides 1, 6 and 7 (Figure 4) and peptides 5 and 8 (Figure S2) were 
plotted. Previously, we reported that for these peptides, a balanced electronic distribution not 
‘too cationic’ and not ‘too hydrophobic’ is necessary to produce the antifungal effect [18, 24]. 
The results obtained here indicated that such electronic distribution pattern appears to be 
necessary for the antibacterial activity as well. From Figure 4 and Figure S3, it is clear that the 
wheel representations obtained for peptides 5–8 were very similar, showing two clearly 
differentiated facades: the ‘charged one’ (denoted by a dash line in these figures) and a more 
extended ‘uncharged one’ (denoted by a full line). The first face identifies the cationic 
residues accounting for the mutual coulombic binding, and the second face is more extensive 
and is formed by hydrophobic and polar residues. The wheel representations obtained for the 
antibacterial peptides 5–8 were closely related to that previously reported for penetratin 
(peptide 1) [18]. 
 
 
Molecular electrostatic potentials 
The electronic study of peptides 1 and 6 was performed using MEPs [39, 40]. The 
fundamental application in this study was to observe whether the substitution of M by M-[O] 
introduced significant electronic changes in this portion of the peptide structures. The MEPs 
of peptides 1 and 6 are shown in Figure 5. Comparing both MEPs, it is possible to observe the 
different electronic distribution obtained for the zones located in the vicinity of M and M-[O] 
residues for compounds 1 and 6, respectively. Note that M-[O] residue displayed a zone with 
potential values of about 0.133 el.au−3, whereas the M residue shows a more positive green 
zone with potential values in the order of 0.306 el.au−3, which clearly dominates this moiety. 
These results indicate that the replacement of M by M-[O] gives a more polarized potential. 
As previously remarked, it is reasonable to think that this different electronic distribution is 
operative to produce the biological response. 
 
 
Searching novel small-size antibacterial peptides 
Considering the premise ‘the shorter the better’, peptides composed of nine, eight, seven and 
five amino acids residues instead of 16 were synthesized (peptides 9–15, Table 1). Cell 
penetration assays using cell cultures revealed that the C-terminal segment of penetratin (10-
mer to 7-mer analogues) was necessary and sufficient for efficient cell membrane 
translocation [48]. Thus, the 8-mer analogue of penetratin (peptide 9) was synthesized in 
order to test its ability to inhibit bacterial growth. Unfortunately, this shortened penetratin 
analogue was completely inactive (Table 1). Taking into account, the potent antifungal 
activity previously obtained for small-size peptides containing nine amino acids residues [25, 
26], at this point, we decided to test two non-apeptides as possible antibacterial agents. To this 
end, peptides 10 and 11, which were the strongest antifungal peptides of that series, were 
selected. Interestingly, peptide 10 displayed a significant antibacterial activity against all the 
species tested here except P. aeruginosa. It should be noted that this peptide was the only one 
in this group displaying antibacterial effect against S. aureus. Peptides 11 and 12 showed a 
markedly lower effect in comparison with peptide 10. Peptides 11 and 12 only inhibited the 
growth of E. coli and Salmonella sp (Table 1) displaying marginal effects. Thus, the low 
antibacterial activity of peptides 11 and 12 might be attributed to the inadequate balance 
between cationic and hydrophobic residues in their sequences. It should be noted that we 
gradually reduced the number of cationic R residues from peptide 10 (four R), peptide 11 
(three R) and peptide 12 (two R). These results are in agreement with other studies suggesting 
that in the antimicrobial activity of short peptides, the overall composition with respect to 
cationic and lipophilic residues is more important than the order of amino acids [49, 50]. In 
fact, the non-apeptide 13 containing seven cationic amino acids (R or K) in its sequence, 
thereby decreasing the number of hydrophobic residues, was completely inactive. Finally, 
peptides 14 and 15 were also devoid of any antibacterial activity. 
 
 
Conclusions 
In the present study, the synthesis and antibacterial effects of penetratin and analogues 
including derivatives containing methionine sulphoxide residues in their sequences are 
reported. Among the tested peptides, peptides 6 (RQIKIWFQNRRM[O]KWKK-NH2) and 7 
(RQIKIFFQNRRM[O]KFKK-NH2) displayed the most interesting inhibitory effect against E. 
coli ATCC 25922, LM1-E. coli, LM2-E. coli, MI-S. enteritidis and Salmonella sp (LM). Our 
results support the use of the MD simulations for this type of peptides. Such simulations 
provide useful information about the preferred conformations and molecular flexibility of 
penetratin and derivatives, which might be useful to better understand the biological response 
of these peptides. Comparing the results obtained from the conformational analysis using the 
different approaches, we can conclude that in general, these methods predict a helical 
structure for penetratin and its derivatives at the TFE/water environment. These results are in 
agreement with the experimental results obtained from CD measurements. With regard to the 
electronic study, peptide 6 displayed a different electronic behaviour compared with native 
penetratin showing that a single amino acid substitution of M to M-[O] gives rise to 
substantial changes in the antibacterial activity. Taking into account that penetratin has been 
proposed as a universal intracellular delivery vehicle, the antibacterial activity displayed for 
peptides 6 and 7 is very interesting by itself, but it is also important considering its potential 
use as a carrier for other known antibacterial drugs. On the other hand, the possibility of these 
peptides, administered with well-known antibacterial drugs, to exert a synergic effect might 
be evaluated. In addition, we found that the non-apeptide (RQIRRWWQR-NH2) having four 
R residues represents the most efficient motif for high antibacterial activity against the 
different bacteria tested in this study. Thus, we confirmed that the total amount and type of 
cationic and lipophilic residues used in short peptides is important for their antimicrobial 
activity. Our investigation of the antibacterial motif of small-size peptides regarding charge 
and lipophilicity/bulk opens the opportunity for development of novel and structurally diverse 
peptidemimetics. These compounds might provide a new source of antibacterial lead 
structures capable to overcome the pharmaceutical concerns such as high manufacturing 
costs, poor pharmacokinetic properties and low bacteriological efficacy. 
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